Eton Pharmaceuticals, Inc. ETON Net Investment in Lease
Net Investment in Lease at other companies
Other financials
Where this comes from
Reported directly by Eton Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Eton Pharmaceuticals, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Eton Pharmaceuticals, Inc.'s net investment in lease.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Eton Pharmaceuticals, Inc.'s net investment in lease?
- Eton Pharmaceuticals, Inc. (ETON) reported net investment in lease of $301K in Q1 2026.
- How has Eton Pharmaceuticals, Inc.'s net investment in lease changed year-over-year?
- Eton Pharmaceuticals, Inc.'s net investment in lease increased by 90.5% year-over-year, from $158K to $301K.
- What is the long-term trend for Eton Pharmaceuticals, Inc.'s net investment in lease?
- Over 5 years (2020 to 2025), Eton Pharmaceuticals, Inc.'s net investment in lease has grown at a 9.7% compound annual growth rate (CAGR), from $195K to $310K.